Your browser doesn't support javascript.
loading
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease.
Chisari, L M; Malaguarnera, S; Grasso, A; Malaguarnera, M; Chisari, G; Borzì, A M; Chisari, C G.
Afiliação
  • Chisari LM; Department of Biomedical and Biotechnological Sciences, University of Catania.
  • Malaguarnera S; Research Centre "The Great Senescence", University of Catania.
  • Grasso A; Department of Biomedical and Biotechnological Sciences, University of Catania.
  • Malaguarnera M; Research Centre "The Great Senescence", University of Catania.
  • Chisari G; Department of Biomedical and Biotechnological Sciences, University of Catania.
  • Borzì AM; Research Centre "The Great Senescence", University of Catania.
  • Chisari CG; Department of Neurosciences - University of Catania.
Clin Ter ; 170(5): e357-e363, 2019.
Article em En | MEDLINE | ID: mdl-31612193

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasodilatadores / Síndromes do Olho Seco / Caminhada / Doença Arterial Periférica / Cilostazol / Claudicação Intermitente Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasodilatadores / Síndromes do Olho Seco / Caminhada / Doença Arterial Periférica / Cilostazol / Claudicação Intermitente Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article